Transaction · 0001231919-26-001503
LYCALycia Therapeutics, Inc.
Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P., 10%, reported an open-market or private purchase at Lycia Therapeutics, Inc. involving 8729.000000 shares for an estimated $225557.36. Reported holdings after the transaction were 6794166.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market buySEC transaction code P10%
- Trade date
- Oct 27, 2026
- Filing date
- Oct 27, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 6,785,437 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
LYCA price since this filing
Daily closing prices, with the filing date and available return windowsLYCA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001231919-26-001503 Common Stock
- Transaction date
- Oct 27, 2026 Filed Oct 27, 2026, 10:38 PM · 0d delay
- Shares
- 8,729 sh $25.84 per share
- Estimated value
- $225k Computed from shares × price
- Holdings after
- 6,794,166 sh Indirect · By Funds
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Repeat Buyer 10% Owner Buy
Filing-only score
+42 points
Compact filing score computed from stored Form 4 facts. Version v1.
Strong filing signal
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - ten_percent_owner_buy+4 points
is_ten_percent_owner = true
10% beneficial owner open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window. - repeat_buyer+8 points
repeat-buyer signal matched
Same insider bought again within the configured window. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector No10% YesOther No
Footnotes & amended
- F1
Consists of (i) 11,163 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 1,118 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 12,279 shares held…
- F2
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.00 to $25.99 inclusive. The Reporting Persons undertake…
- F3
VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own the shares held by VHCP3 and VHCP Co-3. Bong Koh and Nimish Shah…
- F4
VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCP EG and may be deemed to beneficially own the shares held by VHCP EG. Bong Koh and Nimish Shah are the voting members of VHCPMEG and m…
- F5
Consists of (i) 12,898 shares held by VHCP3; (ii) 1,292 shares held by VHCP Co-3; and (iii) 14,189 shares held by VHCP EG.
- F6
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.00 to $26.25 inclusive. The Reporting Persons undertake…
- F7
Consists of (i) 24,061 shares held by VHCP3; (ii) 2,410 shares held by VHCP Co-3; and (iii) 26,468 shares held by VHCP EG.
- F8
Consists of (i) 828,479 shares held by VHCP3; (ii) 82,885 shares held by VHCP Co-3; (iii) 3,216,639 shares held by VHCP EG; and (iv) 651,790 shares held by Venrock Healthcare Capital Partners XP, L.P.…
- F9
Each share of Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-0.221793422 basis upon the closing of the Issuer's ini…
- F10
Consists of (i) 852,540 shares held by VHCP3; (ii) 85,295 shares held by VHCP Co-3; (iii) 3,243,107 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
- F11
VHCP Management XP, LLC ("VHCPMXP") is the general partner of VHCP XP and may be deemed to beneficially own the shares held by VHCP XP. Bong Koh and Nimish Shah are the voting members of VHCPMXP and m…
- F12
Consists of (i) 883,750 shares held by VHCP3; (ii) 88,472 shares held by VHCP Co-3; and (iii) 972,222 shares held by VHCP EG.
- F13
Consists of (i) 1,736,290 shares held by VHCP3; (ii) 173,767 shares held by VHCP Co-3; (iii) 4,215,329 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
- F14
Consists of (i) 3,755 shares held by VHCP3; (ii) 376 shares held by VHCP Co-3; and (iii) 4,130 shares held by VHCP EG.
- F15
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.82 to $27.00 inclusive. The Reporting Persons undertake…
- F16
Consists of (i) 1,740,045 shares held by VHCP3; (ii) 174,143 shares held by VHCP Co-3; (iii) 4,219,459 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
- F17
Consists of (i) 3,967 shares held by VHCP3; (ii) 397 shares held by VHCP Co-3; and (iii) 4,365 shares held by VHCP EG.
- F18
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.28 to $26.27 inclusive. The Reporting Persons undertake…
- F19
Consists of (i) 1,744,012 shares held by VHCP3; (ii) 174,540 shares held by VHCP Co-3; (iii) 4,223,824 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
- F20
Consists of (i) 14,120 shares held by VHCP3; (ii) 1,414 shares held by VHCP Co-3; and (iii) 15,533 shares held by VHCP EG.
- F21
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.28 to $27.00 inclusive. The Reporting Persons undertake…
- F22
Consists of (i) 1,758,132 shares held by VHCP3; (ii) 175,954 shares held by VHCP Co-3; (iii) 4,239,357 shares held by VHCP EG; and (iv) 651,790 shares held by VHCP XP.
- F23
Consists of (i) 3,735,368 shares held by VHCP3; (ii) 373,708 shares held by VHCP Co-3; and (iii) 13,033,502 shares held by VHCP EG.
- F24
Consists of (i) 828,479 shares held by VHCP3; (ii) 82,885 shares held by VHCP Co-3; and (iii) 2,890,744 shares held by VHCP EG.
- F25
Consists of (i) 1,469,363 shares held by VHCP EG and (ii) 2,938,728
shares held by VHCP XP.
- F26
Consists of (i) 325,895 shares held by VHCP EG and (ii) 651,790 shares held by VHCP XP.
Related transactions
Same SEC filing0 other transactions
Recent company activity
LYCA0 recent txs